{"pmid":32390495,"title":"Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.","text":["Balancing the Covid-19-motivated vascular access guidelines and patient-centred care of pre-dialysis candidates.","The recommendations recently proposed by the European and American Vascular Societies in this new 'Covid-19' era regarding the triage of various vascular operations into urgent, emergent and programmed based on the nature of their pathology aim at reserving health care expenses and hospital staff towards managing the current unexpected worldwide pandemic to the highest possible degree. The suggestion for implementation of these changes into real-world practice, however, does not come without a cost. In particular, the recommendation for deferral of access creation in pre-dialysis patients, ethical, socio-economic and medico-legal issues arise which should be seriously taken into consideration. At the end of the day, vascular access creation is the lifeline of haemodialysis patients and the indication for surgery warrants patient-specific clinical judgement rather than 'group labelling'.","J Vasc Access","Georgiadis, George S","Argyriou, Christos","Baktiroglu, Selcuk","Lazarides, Miltos K","Mallios, Alexandros","Tordoir, Jan Hm","32390495"],"abstract":["The recommendations recently proposed by the European and American Vascular Societies in this new 'Covid-19' era regarding the triage of various vascular operations into urgent, emergent and programmed based on the nature of their pathology aim at reserving health care expenses and hospital staff towards managing the current unexpected worldwide pandemic to the highest possible degree. The suggestion for implementation of these changes into real-world practice, however, does not come without a cost. In particular, the recommendation for deferral of access creation in pre-dialysis patients, ethical, socio-economic and medico-legal issues arise which should be seriously taken into consideration. At the end of the day, vascular access creation is the lifeline of haemodialysis patients and the indication for surgery warrants patient-specific clinical judgement rather than 'group labelling'."],"journal":"J Vasc Access","authors":["Georgiadis, George S","Argyriou, Christos","Baktiroglu, Selcuk","Lazarides, Miltos K","Mallios, Alexandros","Tordoir, Jan Hm"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32390495","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/1129729820926860","keywords":["covid-19 vascular guidelines","arteriovenous fistula","catheters","dialysis","dialysis access","economics and health services","ethics and end-of-life issues","pre-dialysis patients"],"topics":["Prevention"],"weight":1,"_version_":1666528580225466368,"score":9.490897,"similar":[{"pmid":32452908,"title":"Hemodialysis Vascular Access Care during the COVID-19 Pandemic.","text":["Hemodialysis Vascular Access Care during the COVID-19 Pandemic.","Dialysis patients are more vulnerable and susceptible to the severe coronavirus disease 2019 (COVID-19) infection due to multiple comorbidities. Since Taiwan has the highest incidence and prevalence of treated end-stage kidney disease worldwide, it is crucial to act in advance to prevent a potential disaster. In the face of the COVID-19 pandemic, we implement proactive infection control measures to prevent it from spreading without sacrificing the dialysis care quality. In this article, we focused on hemodialysis vascular access (HVA) care in particular. As a life-line of hemodialysis (HD) patients, HVA care has a profound impact on the patient's quality of dialysis and life. Specifically, in our facility, the working and office areas of the HD units are separated to reduce cross-infection. All elective procedures for HVA are postponed, and operating rooms equipped with a negative-pressure anteroom are used for the suspected or confirmed COVID-19 patients. Herein, we share how we modified our HVA care policy not only to prevent our patients from COVID-19 infection but also to maintain the quality of HVA care.","J Chin Med Assoc","Yang, Chih-Yu","Wang, Yi-Fang","Ho, Yang","Wu, Cheng-Hsueh","Lee, Chiu-Yang","Tarng, Der-Cherng","32452908"],"abstract":["Dialysis patients are more vulnerable and susceptible to the severe coronavirus disease 2019 (COVID-19) infection due to multiple comorbidities. Since Taiwan has the highest incidence and prevalence of treated end-stage kidney disease worldwide, it is crucial to act in advance to prevent a potential disaster. In the face of the COVID-19 pandemic, we implement proactive infection control measures to prevent it from spreading without sacrificing the dialysis care quality. In this article, we focused on hemodialysis vascular access (HVA) care in particular. As a life-line of hemodialysis (HD) patients, HVA care has a profound impact on the patient's quality of dialysis and life. Specifically, in our facility, the working and office areas of the HD units are separated to reduce cross-infection. All elective procedures for HVA are postponed, and operating rooms equipped with a negative-pressure anteroom are used for the suspected or confirmed COVID-19 patients. Herein, we share how we modified our HVA care policy not only to prevent our patients from COVID-19 infection but also to maintain the quality of HVA care."],"journal":"J Chin Med Assoc","authors":["Yang, Chih-Yu","Wang, Yi-Fang","Ho, Yang","Wu, Cheng-Hsueh","Lee, Chiu-Yang","Tarng, Der-Cherng"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452908","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/JCMA.0000000000000348","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667881798470729728,"score":219.25839},{"pmid":32305384,"pmcid":"PMC7160640","title":"Creation of a vascular surgical Hub responding to the COVID-19 emergency: the italian USL Toscana Centro model.","text":["Creation of a vascular surgical Hub responding to the COVID-19 emergency: the italian USL Toscana Centro model.","Spreading of the COVID-19 pandemic in Italy forced health facilities to drastically change their organization to face the overwhelming number of infected patients needing hospitalization. The USL (Unita Sanitaria Locale) Toscana Centro adopted a protocol of reorganization of the Vascular Surgery Unit during the first difficult weeks of the epidemic, consisting in the creation of a Vascular Hub for urgent cases with a profound reorganization of activities, wards, surgical operators, operating blocks and ICU beds. The aim of this paper is to share the protocol with all the vascular community, hoping to help other institutions to face the emergency during the hard weeks coming.","J Vasc Surg","Chisci, Emiliano","Masciello, Fabrizio","Michelagnoli, Stefano","32305384"],"abstract":["Spreading of the COVID-19 pandemic in Italy forced health facilities to drastically change their organization to face the overwhelming number of infected patients needing hospitalization. The USL (Unita Sanitaria Locale) Toscana Centro adopted a protocol of reorganization of the Vascular Surgery Unit during the first difficult weeks of the epidemic, consisting in the creation of a Vascular Hub for urgent cases with a profound reorganization of activities, wards, surgical operators, operating blocks and ICU beds. The aim of this paper is to share the protocol with all the vascular community, hoping to help other institutions to face the emergency during the hard weeks coming."],"journal":"J Vasc Surg","authors":["Chisci, Emiliano","Masciello, Fabrizio","Michelagnoli, Stefano"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305384","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jvs.2020.04.019","locations":["Italy","italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493395402753,"score":209.75465},{"pmid":32196116,"pmcid":"PMC7184437","title":"Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres.","text":["Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres.","COVID-19, a disease caused by a novel coronavirus, is a major global human threat that has turned into a pandemic. This novel coronavirus has specifically high morbidity in the elderly and in comorbid populations. Uraemic patients on dialysis combine an intrinsic fragility and a very frequent burden of comorbidities with a specific setting in which many patients are repeatedly treated in the same area (haemodialysis centres). Moreover, if infected, the intensity of dialysis requiring specialized resources and staff is further complicated by requirements for isolation, control and prevention, putting healthcare systems under exceptional additional strain. Therefore, all measures to slow if not to eradicate the pandemic and to control unmanageably high incidence rates must be taken very seriously. The aim of the present review of the European Dialysis (EUDIAL) Working Group of ERA-EDTA is to provide recommendations for the prevention, mitigation and containment in haemodialysis centres of the emerging COVID-19 pandemic. The management of patients on dialysis affected by COVID-19 must be carried out according to strict protocols to minimize the risk for other patients and personnel taking care of these patients. Measures of prevention, protection, screening, isolation and distribution have been shown to be efficient in similar settings. They are essential in the management of the pandemic and should be taken in the early stages of the disease.","Nephrol Dial Transplant","Basile, Carlo","Combe, Christian","Pizzarelli, Francesco","Covic, Adrian","Davenport, Andrew","Kanbay, Mehmet","Kirmizis, Dimitrios","Schneditz, Daniel","van der Sande, Frank","Mitra, Sandip","32196116"],"abstract":["COVID-19, a disease caused by a novel coronavirus, is a major global human threat that has turned into a pandemic. This novel coronavirus has specifically high morbidity in the elderly and in comorbid populations. Uraemic patients on dialysis combine an intrinsic fragility and a very frequent burden of comorbidities with a specific setting in which many patients are repeatedly treated in the same area (haemodialysis centres). Moreover, if infected, the intensity of dialysis requiring specialized resources and staff is further complicated by requirements for isolation, control and prevention, putting healthcare systems under exceptional additional strain. Therefore, all measures to slow if not to eradicate the pandemic and to control unmanageably high incidence rates must be taken very seriously. The aim of the present review of the European Dialysis (EUDIAL) Working Group of ERA-EDTA is to provide recommendations for the prevention, mitigation and containment in haemodialysis centres of the emerging COVID-19 pandemic. The management of patients on dialysis affected by COVID-19 must be carried out according to strict protocols to minimize the risk for other patients and personnel taking care of these patients. Measures of prevention, protection, screening, isolation and distribution have been shown to be efficient in similar settings. They are essential in the management of the pandemic and should be taken in the early stages of the disease."],"journal":"Nephrol Dial Transplant","authors":["Basile, Carlo","Combe, Christian","Pizzarelli, Francesco","Covic, Adrian","Davenport, Andrew","Kanbay, Mehmet","Kirmizis, Dimitrios","Schneditz, Daniel","van der Sande, Frank","Mitra, Sandip"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196116","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.1093/ndt/gfaa069","keywords":["covid-19","coronavirus","end-stage kidney disease","haemodialysis","pandemic"],"e_drugs":["Edetic Acid"],"topics":["Prevention"],"weight":1,"_version_":1666138490029473792,"score":196.38257},{"pmid":32337825,"title":"High-Immunological Risk Living Donor Renal Transplant during the COVID-19 Outbreak: Uncertainties and Ethical Dilemmas.","text":["High-Immunological Risk Living Donor Renal Transplant during the COVID-19 Outbreak: Uncertainties and Ethical Dilemmas.","We describe the challenges of performing a high-immunological risk living donor renal transplant during the COVID-19 outbreak. A 42-year-old lady with end-stage renal disease from lupus nephritis had failed peritoneal dialysis due to pleuro-peritoneal leak, failed vascular access creation due to early thrombosis and had recurrent dialysis catheter malfunction. The transplant from her husband was ABO-incompatible and had positive B cell flow crossmatch with multiple donor-specific antibodies. Neither alternative donors nor paired exchange candidates were available. Priority access to deceased donors is limited and unpredictable.","Am J Transplant","Ho, Quan Yao","Chung, Shimin Jasmine","Gan, Valerie Huei Li","Ng, Lay Guat","Tan, Ban Hock","Kee, Terence Yi Shern","32337825"],"abstract":["We describe the challenges of performing a high-immunological risk living donor renal transplant during the COVID-19 outbreak. A 42-year-old lady with end-stage renal disease from lupus nephritis had failed peritoneal dialysis due to pleuro-peritoneal leak, failed vascular access creation due to early thrombosis and had recurrent dialysis catheter malfunction. The transplant from her husband was ABO-incompatible and had positive B cell flow crossmatch with multiple donor-specific antibodies. Neither alternative donors nor paired exchange candidates were available. Priority access to deceased donors is limited and unpredictable."],"journal":"Am J Transplant","authors":["Ho, Quan Yao","Chung, Shimin Jasmine","Gan, Valerie Huei Li","Ng, Lay Guat","Tan, Ban Hock","Kee, Terence Yi Shern"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337825","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/ajt.15949","topics":["Prevention"],"weight":1,"_version_":1666138494283546625,"score":190.15764},{"pmid":32360683,"pmcid":"PMC7187828","title":"COVID-19 Financial Resources for Physicians.","text":["COVID-19 Financial Resources for Physicians.","The appropriate focus in dealing with the COVID-19 pandemic in the United States has been addressing access and delivery of care to the population impacted by the outbreak. All sectors of the U.S economy have been significantly impacted including physicians. Physician groups of all specialties and sizes have experienced the financial impact of the pandemic. Hospitals have received billions of dollars to support and enable them to handle emergencies and cover the cost of the disruption. However, many Vascular Surgeons are under great financial pressure because of postponement of all non-emergency procedures. The Federal Government has announced a myriad of programs in the form of grants and loans to reimburse physicians for some expenses and loss of revenue. It is more than likely that unless the public health emergency subsides significantly, many practices will suffer dire consequences without additional financial assistance. We attempt to provide a concise listing of such programs and resources available to assist Vascular Surgeons who are small businesses in accessing these opportunities.","J Vasc Surg","Satiani, Bhagwan","Zigrang, Todd A","Bailey-Wheaton, Jessica L","32360683"],"abstract":["The appropriate focus in dealing with the COVID-19 pandemic in the United States has been addressing access and delivery of care to the population impacted by the outbreak. All sectors of the U.S economy have been significantly impacted including physicians. Physician groups of all specialties and sizes have experienced the financial impact of the pandemic. Hospitals have received billions of dollars to support and enable them to handle emergencies and cover the cost of the disruption. However, many Vascular Surgeons are under great financial pressure because of postponement of all non-emergency procedures. The Federal Government has announced a myriad of programs in the form of grants and loans to reimburse physicians for some expenses and loss of revenue. It is more than likely that unless the public health emergency subsides significantly, many practices will suffer dire consequences without additional financial assistance. We attempt to provide a concise listing of such programs and resources available to assist Vascular Surgeons who are small businesses in accessing these opportunities."],"journal":"J Vasc Surg","authors":["Satiani, Bhagwan","Zigrang, Todd A","Bailey-Wheaton, Jessica L"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360683","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jvs.2020.04.482","keywords":["cares act","covid-19 outbreak","coronavirus aid","coronavirus economic stabilization act","covid-19","pandemic","relief and economic security act","virus"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138495935053825,"score":170.55017}]}